[ad_1]
By Cara Murez
HealthDay Reporter
FRIDAY, March 31, 2023 (HealthDay Information) — Cats continuously licking and chewing due to a pores and skin situation referred to as feline allergic dermatitis might profit from a brand new generic remedy authorized by the U.S. Meals and Drug Administration.
The FDA authorized Modulis for Cats on March 29, making it the primary generic cyclosporine oral answer for cats with pores and skin circumstances ensuing from this allergic dermatitis.
The immunosuppressant drug tamps down the allergic course of that causes cats with this situation to be itchy.
The treatment accommodates the identical focus and dosage of cyclosporine as an authorized brand-name drug, Atopica for Cats. That treatment was authorized in August 2011.
Cats with this situation will be intensely itchy. They could lick, chew and scratch at their pores and skin and hair.
This could trigger them to develop different pores and skin points, together with miliary dermatitis, lesions referred to as eosinophilic plaques and hair loss.
Cats should be at the least 6 months outdated and weigh 3 kilos to make use of the treatment, which is just out there from a veterinarian.
Individuals who administer this to their cat ought to keep away from by chance ingesting the drug. Don’t eat, drink, smoke or use smokeless tobacco whereas dealing with it, the FDA suggested.
Wash your fingers after giving Modulis for Cats to your pet. Individuals with identified hypersensitivity to cyclosporine ought to keep away from contact with the product, the FDA warned.
The treatment is sponsored by Provetica, LLC, primarily based in Lenexa, Kan. It is available in three sizes.
Extra info
The American Affiliation of Feline Practitioners has extra on feline allergic dermatitis.
SOURCE: U.S. Meals and Drug Administration, information launch, March 29, 2023
[ad_2]
